Published in

Taylor and Francis Group, OncoImmunology, 1(7), p. e1375641

DOI: 10.1080/2162402x.2017.1375641

Links

Tools

Export citation

Search in Google Scholar

A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells

Journal article published in 2017 by Renée C. G. de Bruin, John P. Veluchamy, Sinéad M. Lougheed, Famke L. Schneiders, Silvia Lopez-Lastra, Roeland Lameris, Anita G. Stam, Zsolt Sebestyen, Jürgen Kuball, Carla F. M. Molthoff, Erik Hooijberg, Rob C. Roovers ORCID, James P. Di Santo ORCID, Paul M. P. van Bergen en Henegouwen ORCID, Henk M. W. Verheul ORCID and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO